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Article abstract-We report the clinical, neuropathologic, and genetic studies of a large kindred (family M-ADCA1) 
with autosomal dominant spinocerebellar ataxia type 1 (SCAl), ascertained in 41 members, with clinical data avail- 
able in twenty-two. The mean age of onset was 36.3 * 6.2 years (ages, 26 to 521, the mean duration of the disease was 
15.8 rt 6.5 years (range, 10 to 28 years), and the mean age at death was 54.1 * 9.5 years (ages, 39 to 72). Premonitory 
signs and symptoms appeared earlier than the usual onset symptoms in many of the clinically unaffected patients who 
inherited the mutated SCAl gene. Anticipation was present when we compared the seventh and eighth generations. A 
more severe course of the disease occurred in offspring of affected males. Neuropathologic examination, performed on 
three patients, showed the usual findings of SCA1; Golgi and immunocytochemistry studies suggested primary damage 
of the Purkinje cells. We analyzed the CAG-repeat mutation responsible for the SCAl phenotype in a total of 41 family 
members. There was expansion in 19 subjects (10 clinically affected, seven with early signs and symptoms, and two 
asymptomatic individuals), and all showed heterozygosity, with one allele between 41 and 59 repeats (SCA1 mutation) 
and the other in the range of 6 to 39 repeats (normal range). The clinical analysis of “at risk” patients with the SCAl 
mutation showed that minor signs and symptoms begin before full clinical diagnosis, and these premonitory manifesta- 
tions can herald full development of SCAl by years. 
NEUROLOGY 1995;45:24-30 
The autosomal dominant spinocerebellar ataxias 
(ADCAs) are a group of inherited disorders show- 
ing clinical, neuropathologic, and genetic hetero- 
geneity.’S2 Besides cerebellar manifestations, de- 
mentia, pyramidal signs, and ocular motor and 
spinal cord dysfunction are also present. 
In 1974, Yakura et aP observed linkage between 
one form of dominant ataxia and the HLA locus. 
Later,  Jackson et a14 confirmed t h a t  a form of 
spinocerebellar ataxia (SCA) showed linkage to 
chromosome 6. This locus was named SCA1, and 
this variant of dominant ataxia is known as SCA 
type 1 (SCA1).5 Other SCAl kindreds showed link- 
age with this locus.6-*o The development of markers 
closely linked to SCAl has allowed genetic studies 
in affected famil ie~.~Jl-’~ More recently, Orr et all4 
isolated a 10-kb transcript showing high expression 
in brain and skeletal muscle, containing an  unsta- 
ble trinucleotide (CAG), repeat, which is expanded 
in SCAl patients. This (CAG), repeat expansion is 
the mutation causing SCA1, and the mutated gene 
is now known as the SCAl gene. 
We describe here the clinical, neuropathologic, 
and genetic studies in a large family with dominant 
ataxia (family M-ADCA1) that segregates with the 
SCAl locus and has the (CAG), m ~ t a t i 0 n . l ~  The 
molecular detection of clinically unaffected patients 
has allowed the identification of disease premoni- 
tory manifestations years before the appearance of 
the usual onset symptoms. 
Methods. Genealogic and epidemiologic d a t a .  Ge- 
nealogic data for family M-ADCA1 were obtained for 400 
subjects with a common ancestor born in 1735. Data 
See also page 1 
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Figure 1. Pedigree of M family. 
around and before 1870 were obtained from church 
archives. The pedigree spans over 10 generations (figure 
1). This family has lived for three centuries in the Girona 
area (Catalonia, Spain). 
Clinical and neuropathologic data. Fourteen patients 
were examined by D.G., and clinical data from three hos- 
pitals were obtained for a further eight patients. Age of 
onset, duration of the disease, age a t  death, onset symp- 
toms, and general clinical information were obtained 
from these clinical registers. 
An “at r i s k  subject was defined as “the clinically un- 
affected offspring of an affected individual.” Thirty-three 
asymptomatic at-risk subjects and their offspring (18 
years or older) have been examined. Those at-risk sub- 
jects who had the mutation, as determined by molecular 
genetic studies, composed the “at risklmutated” group, 
whereas those nonmutated individuals composed the “at 
risklnormal” group. All patients were neurologically ex- 
amined at  least once. A questionnaire for all the at-risk 
individuals was prepared in an effort to detect minimal 
or incipient symptoms of the disease. Responses were 
registered and even minor signs of SCA were included. 
A neuropathologic study was carried out on three pa- 
tients: VII-78, VIII-4, and VIII-43. The microscopic study 
was performed on formalin-fixed, dewaxed paraffin sec- 
tions. A detailed description of the changes and a study 
using the Golgi method, and neurofilament and calcium 
binding protein immunocytochemistry, have been re- 
ported elsewhere.16 
Genetic studies. Genetic studies were carried out on 65 
subjects, 10 affected and 55 clinically unaffected individ- 
uals. DNA was obtained from blood lymphocytes for all 
patients except two, from whom samples of brain and 
liver postmortem tissues were used. Pairwise linkage 
analysis for the DNA markers analyzed was performed 
using the frequencies obtained in 200 unrelated individu- 
als of the Spanish population or those published for each 
marker.6J2J7 
Linkage analysis between SCAl and D6S89 and be- 
tween SCAl  and  D6S109 was performed using t h e  
LINKAGE program, version 5.1, with the appropriate 
corrections for age-dependent penetrance, as reported 
p r e v i o ~ s l y . ~ ~ J ~  The CAG repeat a t  the SCAl locus was 
analyzed using the primers and electrophoresis condi- 
tions described elsewhere. 14,15 
Results. Chronologic data. Ataxia was ascertained 
in 41 family members (20 men, 21 women), but 
clinical data were obtained for only 22 of them 
(nine men and 13 women). Eight patients belonged 
to  the seventh generation and 14 t o  the eighth. 
Both sexes were equally at  risk of developing the 
disease. The disease in this family is inherited as 
an autosomal dominant trait with complete pene- 
trance by the age of fifty-two. In 13 subjects, the af- 
fected parent was the father and in nine, the 
mother. There were 43 known at-risk subjects (23 
men and 20 women); of these, 33 were clinically 
January 1996 NEUROLOGY 45 26 
Table 1. Chronologic data* 
20 25 30 35 40 45 50 55 
Ago (yomra) 
?igure 2. Cumulative onset probability curve of M family. 
studied and genetically analyzed (figure 1). 
6.2 years. A 
cumulative penetrance curve was constructed from 
affected individuals by the method of Ott19 (figure 
2). The mean duration of the disease was 15.8 * 6.5 
years. The mean age at death was 54.1 * 9.5 years. 
There were no sex-related differences in these data, 
but younger onset (anticipation) and shorter dura- 
tion of the disease, with earlier death, were ob- 
served in the eighth generation compared with the 
seventh. Differences in the mean duration of the 
disease and the mean age at death (table 1) sug- 
gested a trend toward a shorter course of disease 
and an earlier age at death for offspring of an af- 
fected father compared with offspring of an affected 
mother. 
Onset symptoms in SCAl patients. Ataxia was 
the initial reported symptom in 17 patients. In 14 
of these patients, ataxia was the only symptom at 
presentation; in two patients, ataxia was accompa- 
nied with dysarthria, and in one, with fatigue. In 
another patient, the disease began with fatigue 1 
year before the development of ataxia and dys- 
arthria; in two others, dysarthria was the first sign 
of disease; and in the remaining two patients, the 
initial symptom was unknown. 
Clinical findings in  SCAl patients. A complete 
cerebellar syndrome developed in all patients dur- 
ing the course of the disease, with ataxia,  
dysarthria, titubation, dysdiadochokinesia, and 
dysmetria. Pyramidal signs were detected in 10 of 
22, dementia in eight, and ocular motor disorders 
in nine. 
Cognitive dysfunction was present in two clinical 
forms. In some cases, a frontal-like syndrome pre- 
sented with euphoria and emotional lability, but in 
most patients, a change in the usual behavior ap- 
peared only in the last years of the disease, with 
nocturnal shouting and crying, irritability, and ag- 
gressiveness. A neuropsychological study was im- 
possible in these patients. 
Ocular motor findings in some of our patients in- 
cluded an absence of optokinetic nystagmus, up- 
ward gaze palsy, and lid retraction. Dysphagia 
The mean age of onset was 36.3 
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Mean age Mean Mean age 
at onset duration at death 
Total 36.3 i 6.2 15.8 i 6.5 54.1 i 9.5 
N 22 14 14 
Range (26-52) (10-28) (39-72) 
Seventh 40.3 i 7.6 20.8 i 5.1 62.3 i 6.3 
N 8 8 8 
Eighth 33.4 i 8.6 15.4 i 7.5 45.3 i 6.8 
N 14 6 6 
generation 
generation 
P <  0.004 0.005 0.001 
Mother 38.9 i 8.5 25.2 i 4.2 65.1 f 3.8 
affected (n) (9) (3) (3) 
Father 36.1 i 7.9 15.6 i 4.5 51.2 i 8.9 
affected (n) (13) (11) (11) 
N 22 14 14 
P <  0.29 0.023 0.024 
* Ages and duration are measured in years i SD. 
with choking was a minor but constant finding in 
the M-ADCA1 family. When questioned, all pa- 
tients had had dysphagia since the onset of disease 
although without serious problems until the last 
years of the clinical course. 
Nine patients had weight loss and wasting that 
was not related to dysphagia. It started during the 
midcourse of the disease and was not modified by 
diet or drug therapy. Amyotrophy was also a very 
frequent finding, paralleling cachexia. A progres- 
sive restrictive respiratory failure with impaired 
cough mechanisms was observed in five patients, 
but this number is probably an underestimation 
because some patients have not been properly in- 
vestigated. Respiratory failure was probably re- 
lated to the anterior horn disease and amyotrophy. 
Chorea, torticollis, tongue atrophy, fasciculations, 
sphincter dysfunction, and deep sensation loss 
were less frequent findings. 
Fourteen of the patients are dead. In 11, death 
was caused by pneumonia, probably combined with 
restrictive respiratory failure; one patient died of a 
pneumothorax, and another patient from sepsis. 
The cause of death was unknown for the remaining 
patient. 
Neuropathologic studies. The most remarkable 
gross features were atrophy of the ventral part of 
the pons and middle cerebellar peduncles, with 
variable shrinkage of the cerebellum and inferior 
olives. 
In the microscopic study, the cerebellar cortex 
showed loss of Purkinje cells and variable loss of 
granule cells. Neuron loss and gliosis occurred in 
the dentate nuclei. The inferior olives exhibited re- 
duced numbers of neurons and increased numbers 
of astrocytes. Similar findings were present in the 
pontine nuclei. Involvement of the reticular forma- 
Number of repeats 
Figure 3. (CAG), repeats 
in M family. The at-risk 
unaffected group is at left 
(shaded). The affected 
group is at right (in 
white), with the three 
asymptomatic subjects 
(inserted horizontal bars). 
Age is the current age for 
the at-risk unaffected; 
age of onset is the age of 
the first detected 
symptom and sign for the 
affected group. 
tion, nucleus ambiguus, dorsal nucleus of the vagus 
nerve, and hypoglossal nucleus was variable from 
one patient to  another. Loss of neurons, pigment 
deposition in the neuropil, and gliosis were found 
in the substantia nigra. The striatum and more 
specifically the putamen, pallidum, and subthalam- 
ic nucleus were also variably affected. The cerebral 
cortex was normal in every patient. 
Golgi and calbindin immunocytochemistry stud- 
ies showed loss of dendrites, reduced dendritic ar- 
bors, decreased formation of proximal spines, ab- 
normal accumulation of neurofilaments, and early 
formation of axonal spheroids. These findings sug- 
gest primary damage of Purkinje cells in SCA1.16 
SCAl (CAG), expansion analysis. Linkage stud- 
ies showed that the disease was in complete link- 
age disequilibrium with D6S89.15 Analysis of the 
CAG-repeat mutation, responsible for the SCAl 
phenotype, showed that 10 clinically affected and 
nine at-risk individuals were heterozygous, with 
the disease allele between 41 and 59 repeats. Anal- 
ysis of 60 normal individuals showed a total of 13 
different alleles ranging between six and 39 re- 
peats. The difference in repeat size between af- 
fected and unaffected individuals was very narrow 
in the M-ADCA1 family, with a 39-repeat allele as- 
sociated with a normal phenotype and a 41-repeat 
allele associated with SCA1.15 There was an in- 
verse correlation between the number of CAG re- 
peats and the age of onset of the disease (figure 3). 
The mean number of repeats in affected individ- 
uals of the eighth generation was 47.7 * 4.5 and of 
the ninth generation, 53.5 * 3.8 (p  c 0.05) (table 2). 
Considering sex, in affected men the mean number 
Table 2. Mean CAG repeats in relation to sex, 
generation, and parental sex 
I 
Mean 
repeats * SD 
Men (n = 8) 
Women (n = 11) 
48.0 * 3.77 NS 
49.8 f 5.47 
Eighth generation (n = 13) 47.7 f 4.53 ~ o.05 
Ninth generation (n = 6) 
Father affected (n = 5) 50.2 * 3.43 NS 
Mother affected (n = 14) 
53.5 * 3.87 
49.2 * 5.85 
I 
of repeats was 48.0 * 3.77 and in affected women, 
49.8 * 5.47. We observed that when affected fa- 
thers passed on the mutated SCAl gene, the in- 
crease in the number of CAG repeats found in their 
offspring was larger (50.2 * 3.43) than that seen 
when it was passed on by affected mothers (49.2 * 
5.85). However, this difference is not statistically 
significant. We also observed that none of five sons 
of an affected father presented the CAG-repeat al- 
lele in the affected range ( p  = 0.031); in this line, 
the disease was transmitted through four genera- 
tions only by males. In another line in which the 
disease was transmitted only by women through 
four generations, only one of six sibs had a 47 CAG- 
repeat disease allele. 
Six parent-child transmissions of the CAG re- 
peat were studied in family M-ADCA1. In all cases, 
the mother was affected. We detected a contraction 
in the number of CAG repeats (from 51 to 50) in an 
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Table 3. Age at onset of early signs and symptoms 
and CAG-repeat number in presymptomatic 
analysis of SCAl in family M-ADCA1 
Repeats Age/Sex Signs and symptoms 
41 
41 
47 
47 
49 
50 
52 
53 
59 
18m 
25/M 
39m 
39/M 
28/F 
27/M 
18/M 
25m 
18/F 
Asymptomatic 
Asymptomatic 
Unsustained gaze-evoked upward- 
Right upper limb tremor 
Occasional unsteadiness 
Unsteadiness when rising from a 
chair 
Unsustained gaze-evoked upward- 
beating nystagmus 
Slight tremor in hands 
Occasional unsteadiness 
beating nystagmus 
I 
otherwise healthy 27-year-old individual who re- 
ported occasional unsteadiness,  whereas his 
mother, with 51 repeats, had had a well-defined 
ataxia at the same age. Stabilization of the repeat 
number (41 repeats) was observed in two subjects, 
while in the other three patients, the repeat ex- 
panded by three copies (from 50 to 53 and from 49 
to 52) and by two triplets (from 51 to 53). 
Early manifestations in at-risklmutated subjects. 
Nine of 33 at-risk individuals were diagnosed for 
SCAl by genetic studies (at-riswmutated). These 
patients did not fulfil the clinical criteria of SCA1. 
In some patients, minor symptoms of SCAl were 
reported, such as occasional unsteadiness or insta- 
bility after rising from a chair, or light signs were 
discovered by neurologic examination, such as brief 
unsustained gaze-evoked upward-beating nystag- 
mus, right upper limb tremor, light bilateral 
tremor in hands, hyperreflexia, slight ataxia, and 
lingual tremor or dysarthria (table 3). None of 
these nine patients considered themselves affected 
by SCA1. Only two of the at-riswmutated individu- 
als were found to be completely normal on exami- 
nation, and they did not report abnormalities in 
the questionnaire. None of the 24 subjects catego- 
rized as at-riskhormal had abnormalities in the 
questionnaire or on neurologic examination. 
Discussion. Family M-ADCA1 is one of the largest 
and most homogeneous SCAl kindreds linked to  
chromosome 6p that has been described. Chrono- 
logic data of age of onset, mean duration of disease, 
and mean age at death in family M-ADCA1 are 
similar to those of other SCAl families.4*7-9,20*21 
We found high frequency of dysphagia, with the 
early appearance of choking. Cachexia not related 
to dysphagia during the midcourse of the disease 
was present in half the patients. The progressive 
restrictive respiratory failure detected in SCAl pa- 
tients may be a consequence of an associated mo- 
toneuron disease but has not previously been recog- 
nized as an important sign of SCA1; this feature 
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complicates the course of the disease. 
Neurologic examination of at-risk patients re- 
vealed subtle signs. A slight tremor, unsustained 
gaze-evoked upward-beating nystagmus, or a sen- 
sation of instability when rising from a chair or 
when going down stairs are characteristic hall- 
marks of SCA. We established that (1) minor signs 
and symptoms begin early in the course of disease, 
before full clinical diagnosis; (2) these manifesta- 
tions are intermittent in some patients before the 
inexorable course begins; (3) emotional factors can 
occasionally cause a symptom or a sign to appear, 
and it subsides days or weeks later; and (4) in an 
at-risk subject, these mild symptoms and signs can 
herald the full development of SCAl by years. 
The disease in family M-ADCA1 was tightly 
linked to marker D6S89 at 6p, and an analysis of 
the CAG repeat showed an expansion above normal 
values in 10 clinically affected individuals, seven 
individuals with early minor signs and symptoms, 
and two asymptomatic indi~idua1s.l~ There is a cor- 
relation between the number of repeats and the age 
of onset of SCA1, with a higher number of repeats 
correlating with an earlier age of onset.14,15 Juve- 
nile onset of SCAl has been found to be associated 
with 60 or more repeats.14 We have shown that the 
largest number of repeats in the M-ADCA1 kindred 
was 59 in a clinically unaffected 18-year-old at-risk 
female. Anticipation and juvenile onset were pres- 
ent in other SCAl k i n d r e d ~ ~ l ' ~ . ~ ~  with numbers of 
(CAG), repeats between 69 and 81. We have not de- 
tected young or juvenile-onset patients, concordant 
with the smaller mean number of (CAG), repeats 
(average, 48) in our family. 
The size of the CAG repeat increased from the 
eighth generation to the ninth generation in family 
M-ADCA1, as found in other SCAl kindreds,14 pro- 
viding a basis for the molecular mechanism in- 
volved in anticipation for SCA1. In Huntington's 
disease (HD),22 myotonic dystrophy (DM),23*24 and 
in two large SCAl families,14 there is a preponder- 
ance of male transmission in juvenile patients de- 
tected. In family M-ADCA1, we have detected a 
shorter course of the disease and an earlier age at 
death in the offspring of affected fathers compared 
with the offspring of affected mothers15; this was 
not usually found in other SCAl families,4~7-9~20-21 
but the difference between the number of repeats 
in both groups was not significant. An early onset 
of SCA symptoms has previously been associated 
with a shorter and worse course of the disease.25 
This was not the rule in family M-ADCA1, in which 
we did not find a statistical correlation between the 
age of onset and the duration of the disease (data 
not shown). For the same number of repeats, dis- 
ease onset is earlier in men than in women. An- 
other feature in family M-ADCA1 was a continuous 
male transmission ending in five offspring of an af- 
fected male without any of them being affected. 
Moreover, an only-female transmission ended in 
only one sib of six affected. 
In some cases, absence of CAG expansion was 
present with maternal transmission of the disease, 
as previously observed in DM24,26 and in HD.22 Con- 
traction (a decrease of the size of the CAG repeat) 
may be present in DM,23v24,26 in HD,22 and in fragile 
X These peculiar situations suggest 
that other mechanisms exist to restrict the trans- 
mission of the SCAl mutation. 
SCAl is a trinucleotide repeat disease like DM,24 
HD,22 fragile X syndrome,27 and Kennedy’s dis- 
ease.Z8 In most of the descendants, the repeat ex- 
pands, but in others it stabilizes or contracts, and 
these mechanisms seem to act simultaneously in 
different branches of a kindred. In some branches, 
the  disease seems t o  increase in  frequency, 
whereas in others i t  decreases and even disap- 
pears. The recent discovery of the CAG-repeat ex- 
pansion has improved presymptomatic diagnosis of 
SCAl and is an important tool for studying the 
characteristics of the genetic transmission of this 
disease.14J5 
The classification of autosomal dominant SCAs 
may change rapidly. Besides the first type of dominant 
ataxia linked to chromosome 6 (SCA1),3,4,6-8,11-15,20,21 
recent advances suggest the existence of more than 
four different genetic types of dominant ataxia. A sec- 
ond locus (SCA2)  has been linked to chromosome 12 
in Cuban and other  pedigree^.'^^^^^^^ The locus re- 
sponsible for Machado-Joseph disease (MJD), with 
a suggested name of SCA3, another neurodegen- 
erative process related to SCA, maps to  chromo- 
some 14.31 Finally, genetic studies have excluded 
linkage to chromosomes 6 and 12 in several French 
families with a different phenotype of MJD, sug- 
gesting a fourth locus (SCA4).32 Nevertheless, al- 
though the total number of different SCA loci re- 
mains unknown, autosomal dominant ataxia het- 
erogeneity is beginning to be classified at the molec- 
ular level. Knowledge about the SCAl gene and the 
mutation mechanism of this disease should improve 
our understanding of other dominant ataxias. 
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Assessment of MRI criteria for MS 
in Japanese MS and HANVT SP 
Y. Kuroda, MD; M. Matsui, MD; M. Yukitake, MD; K. Kurohara, MD; H. Takashima, MD; 
Y. Takashima, MD; C. Endo, MD; A. Kato, MD; and F. Mihara, MD 
Article abstract-We evaluated the usefulness of the MRI criteria for multiple sclerosis (MS) proposed by Paty et a1 
and Fazekas et a1 in 36 Japanese MS patients, using HTLV-I-associated myelopathy (HAM)ltropical spastic parapare- 
sis (TSP) as the control. Although 30 of 36 HAMPTSP patients had multiple white matter lesions on T,-weighted cra- 
nial MRI, only two fulfilled the MRI criteria for MS. At the same time, 31 of the 36 MS patients fulfilled the primary 
MRI criterion, yielding 93% specificity and 86% sensitivity for the criterion. MS has disease-specific MRI abnormali- 
ties. 
NEUROLOGY 1995;45:30-33 
Human T-cell lymphotropic virus type I (HTLV-I)- 
associated myelopathy (HAM)/tropical spastic 
paraparesis (TSP) is a chronic inflammatory dis- 
ease primarily affecting the spinal Although 
the pathogenesis remains unclear, much evidence 
suggests that HAM/TSP is similar to multiple scle- 
rosis (MS); the presence of pleocytosis, increased 
IgG and oligoclonal IgG in the CSF,1-3 predominant 
occurrence in adult and efficacy of corti- 
costeroids and interferon-a or -p1,4-6 are reported in 
both conditions. The neuropathologic findings con- 
sist of demyelination and T-cell infiltrates,3Js8 and 
T,-weighted MRI detects multifocal lesions in the 
cerebral white matter in both cond i t ion~ .~J~  Re- 
cently, Paty et al11J2 and Fazekas et al13J4 proposed 
MRI criteria for MS. Although they verified the 
usefulness of the criteria in controlled studies, none 
of the studies included HAM/TSP as the con- 
trol.11J3J4 We assessed the specificity of the MRI 
criteria for MS in Japanese MS and HAMfTSP pa- 
tients. 
Methods. Brain MRI findings in 36 patients with clini- 
cally definite or  probable MS and 36 patients with clini- 
cally definite HAMPTSP were reviewed. The diagnosis of 
MS was made according to the criteria of Schumacher et 
a1,16 and that of HAMA'SP according to the criteria of 
Osame et a1.16 The MS group consisted of 29 women and 
seven men, and the HAMITSP group comprised 22 
women and 14 men. The mean age at  MRI was 44 years 
(range, 13 to 70 years) for the MS group and 54 years 
(range, 28 to 72 years) for the HAMPTSP group. Although 
we included five HAM/TSP patients with hypertension 
and one HAM/TSP patient with CREST syndrome and 
Sjogren's syndrome, no patient in either group had a his- 
tory of cerebral stroke. 
All MRI studies were performed a t  a high field 
strength (1.5 tesla) on a superconducting General Elec- 
tric Signa MR imaging system. T,-weighted spin-echo 
(SE) images were obtained using a repetition time of 
2,000 msec, an echo time of 80 msec, and 1 excitation (SE 
2,000/80/1) in the axial plane. Intermediate weighted (SE 
2,000120 or 30) images were obtained simultaneously. Tl- 
weighted SE images (SE 40012012 or 600125l2) were also 
obtained in all patients. The multislice technique was 
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